Inhibitors of glycogen synthase kinase 3
Details for Australian Patent Application No. 2001295026 (hide)
International Classifications
Event Publications
3 April 2008 Application Accepted
Published as AU-B-2001295026
10 April 2008 Assignment before Grant
Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc. 2002
31 July 2008 Standard Patent Sealed
5 November 2009 Alteration of Name
The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. 2002
29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser